Page 3 of 8
PY8.1-7 | Endocrine Physiology — SDL Guide (Part 3)
Type 1 vs Type 2 Diabetes: Pathophysiology
Type 1 Diabetes Mellitus (T1DM):
- Absolute insulin deficiency due to autoimmune destruction of β cells
- Without insulin: glucose cannot enter cells → hyperglycaemia; fat breakdown unchecked → ↑ ketone bodies (acetoacetate, β-hydroxybutyrate) → diabetic ketoacidosis (DKA)
- DKA: Kussmaul breathing (compensating metabolic acidosis), fruity breath (acetone), dehydration, hyperkalaemia initially (then hypokalaemia with insulin treatment)
- Treatment: insulin (exogenous replacement)
Type 2 Diabetes Mellitus (T2DM) — the epidemic:
- Insulin resistance (initially) + progressive β cell failure
- Mechanism of insulin resistance: ↑ visceral fat → free fatty acids + adipokines (resistin, TNF-α) → impair insulin signalling at post-receptor level (IRS-1 phosphorylation impaired)
- Initially: β cells compensate by secreting MORE insulin (hyperinsulinaemia). Blood glucose normal at the cost of high insulin.
- Eventually: β cells exhaust → insulin secretion falls → hyperglycaemia.
- T2DM is NOT associated with DKA (because residual insulin suppresses ketogenesis) but can develop hyperosmolar hyperglycaemic state (HHS) — extreme hyperglycaemia without ketosis.
Complications (long-term hyperglycaemia):
- Microvascular: Nephropathy, retinopathy, neuropathy — all from glycation of basement membranes and oxidative stress
- Macrovascular: Atherosclerosis → MI, stroke, PVD
Cross-subject link (BI): Advanced glycation end products (AGEs) that damage the GBM in diabetic nephropathy are the same biochemical products you studied in BI (non-enzymatic glycation of proteins).
Figure: Type 1 vs Type 2 Diabetes: Pathophysiology
Figure: Type 1 vs Type 2 Diabetes: Pathophysiology
Figure: Type 1 vs Type 2 Diabetes: Pathophysiology
SELF-CHECK — : Glucose Homeostasis & Diabetes
A 16-year-old with T1DM misses his insulin injection for 24 hours. His blood gas shows pH 7.18, HCO₃⁻ 8 mEq/L, glucose 480 mg/dL. What is the primary mechanism causing the metabolic acidosis?
A. Excess lactic acid from anaerobic glycolysis
B. Renal failure causing inability to excrete H⁺
C. Unchecked lipolysis and ketogenesis due to absence of insulin, with glucagon driving ketone production
D. Hyperglycaemia directly acidifying the blood
Reveal Answer
Answer: C. Unchecked lipolysis and ketogenesis due to absence of insulin, with glucagon driving ketone production
A patient with T2DM has serum K⁺ of 6.2 mEq/L. The doctor gives insulin + glucose infusion. Why does insulin lower serum K⁺?
A. Insulin increases renal K⁺ excretion via aldosterone stimulation
B. Insulin activates Na-K-ATPase in muscle and fat cells, shifting K⁺ into cells
C. Insulin dilutes K⁺ by increasing blood volume
D. Insulin blocks K-ATP channels in the kidney
Reveal Answer
Answer: B. Insulin activates Na-K-ATPase in muscle and fat cells, shifting K⁺ into cells
Calcium Homeostasis: PTH, Vitamin D, and Calcitonin
Normal serum calcium: 8.5–10.5 mg/dL (or 2.1–2.6 mmol/L). About 50% is ionised (active); 40% protein-bound (to albumin — adjusts with albumin levels); 10% complexed.
Calcium is regulated by three hormones acting on three target organs (bone, kidney, gut):
PTH (Parathyroid Hormone) — the main defender against hypocalcaemia:
Released by chief cells of parathyroid glands when Ca²⁺ falls (sensed by calcium-sensing receptor, CaSR). PTH is the major short-term regulator.
Actions (all raise blood calcium):
- Bone: ↑ Osteoclast activity → bone resorption → releases Ca²⁺ and PO₄³⁻ into blood
- Kidney: ↑ Ca²⁺ reabsorption in DCT; ↓ phosphate reabsorption (phosphaturia); ↑ activation of Vitamin D (1α-hydroxylase in PCT)
- Gut: Indirect — via Vitamin D activation
Vitamin D (Calcitriol — 1,25-dihydroxycholecalciferol):
Activation pathway:
- Skin: UV light → 7-dehydrocholesterol → cholecalciferol (Vit D3)
- Liver: 25-hydroxylation → 25-OH Vit D3 (storage form; measured in blood tests)
- Kidney: 1α-hydroxylation (stimulated by PTH and hypophosphataemia) → 1,25-(OH)₂D₃ (calcitriol — active form)
Actions: ↑ Ca²⁺ and PO₄³⁻ absorption from gut (via TRPV6 channels); ↑ bone mineralisation; feedback inhibits PTH.
Calcitonin (from parafollicular C cells of thyroid):
Released when Ca²⁺ rises. Acts to LOWER calcium: ↓ osteoclast activity. Physiological role is MINOR in humans (people without calcitonin have normal Ca²⁺). Used pharmacologically (nasal calcitonin for Paget's disease, osteoporosis).
Cross-subject link (BI): Vitamin D activation cascade involves cytochrome P450 enzymes in liver and kidney — studied in BI enzyme biochemistry.
Figure: Calcium Homeostasis: PTH, Vitamin D, and Calcitonin
Figure: Calcium Homeostasis: PTH, Vitamin D, and Calcitonin
Figure: Calcium Homeostasis: PTH, Vitamin D, and Calcitonin
Clinical Features of Calcium Disorders
Hypocalcaemia (Ca²⁺ < 8.5 mg/dL):
Causes: Hypoparathyroidism (post-thyroidectomy), Vit D deficiency (commonest in India), malabsorption, CKD (1α-hydroxylase impaired), hypomagnesaemia.
Clinical features — all due to increased neuronal excitability:
- Tetany: Involuntary carpopedal spasm (hand = obstetrician's hand)
- Trousseau's sign: Inflate BP cuff > systolic → carpal spasm within 3 minutes
- Chvostek's sign: Tap facial nerve anterior to ear → ipsilateral facial muscle twitch
- Perioral tingling, paraesthesias
- Severe: laryngospasm (stridor), seizures, prolonged QT on ECG → cardiac arrhythmia
Treatment: IV calcium gluconate (emergency), oral Vit D + calcium (maintenance), calcitriol in CKD.
Hypercalcaemia (Ca²⁺ > 10.5 mg/dL):
Causes (mnemonic: Bones, Stones, Moans, Groans, Psychic Overtones):
- Most common: Primary hyperparathyroidism (PTH adenoma), malignancy (bone mets, PTHrP-secreting tumours)
Clinical features:
- Bones: Osteitis fibrosa cystica (severe PTH → bone resorption)
- Stones: Renal calculi (hypercalciuria → calcium oxalate or phosphate stones)
- Moans: Abdominal pain, constipation, peptic ulcer (↑ gastric acid via gastrin)
- Groans: Polyuria/polydipsia (hypercalcaemia impairs ADH action in collecting duct)
- Psychic overtones: Depression, confusion, psychosis
Treatment: IV fluids + furosemide (loop diuretics increase renal Ca²⁺ excretion), bisphosphonates.
Figure: Clinical Features of Calcium Disorders
Figure: Clinical Features of Calcium Disorders
Figure: Clinical Features of Calcium Disorders